Cargando…

Optimised and Rapid Pre-clinical Screening in the SOD1(G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)

The human SOD1(G93A) transgenic mouse has been used extensively since its development in 1994 as a model for amyotrophic lateral sclerosis (ALS). In that time, a great many insights into the toxicity of mutant SOD1 have been gained using this and other mutant SOD transgenic mouse models. They all de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mead, Richard J., Bennett, Ellen J., Kennerley, Aneurin J., Sharp, Paul, Sunyach, Claire, Kasher, Paul, Berwick, Jason, Pettmann, Brigitte, Battaglia, Guiseppe, Azzouz, Mimoun, Grierson, Andrew, Shaw, Pamela J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158065/ https://www.ncbi.nlm.nih.gov/pubmed/21876739 http://dx.doi.org/10.1371/journal.pone.0023244

Ejemplares similares

Early Detection of Motor Dysfunction in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels
por: Bennett, Ellen J., et al.
Publicado: (2014)

Comparison of stimulus-evoked cerebral hemodynamics in the awake mouse and under a novel anesthetic regime
por: Sharp, Paul S., et al.
Publicado: (2015)

Corrigendum: Comparison of stimulus-evoked cerebral hemodynamics in the awake mouse and under a novel anesthetic regime
por: Sharp, Paul S., et al.
Publicado: (2015)

Dysregulation of the complement cascade in the hSOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis
por: Lee, John D, et al.
Publicado: (2013)

Caudal–Rostral Progression of Alpha Motoneuron Degeneration in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Kirby, Alastair J., et al.
Publicado: (2022)

The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1(G93A) and TDP-43(Q331K) transgenic mouse models of ALS
por: Keerie, Amy, et al.
Publicado: (2021)

Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Yan, Lina, et al.
Publicado: (2018)

Rosmarinic Acid Alleviates Neurological Symptoms in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
por: Seo, Ji-Seon, et al.
Publicado: (2015)

Vascular Origins of BOLD and CBV fMRI Signals: Statistical Mapping and Histological Sections Compared
por: Kennerley, Aneurin J, et al.
Publicado: (2010)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model
por: Kim, Renaid B., et al.
Publicado: (2016)

Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
por: Sugimoto, Kazuo, et al.
Publicado: (2021)

Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
por: Molnar-Kasza, Agnes, et al.
Publicado: (2021)

Seizure epicenter depth and translaminar field potential synchrony underlie complex variations in tissue oxygenation during ictal initiation
por: Harris, Samuel S., et al.
Publicado: (2018)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
por: Lee, Albert J. B., et al.
Publicado: (2023)

A comprehensive assessment of the SOD1(G93A) low-copy transgenic mouse, which models human amyotrophic lateral sclerosis
por: Acevedo-Arozena, Abraham, et al.
Publicado: (2011)

Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1(G93A) transgenic mouse model
por: Shang, Hai‐Yan, et al.
Publicado: (2019)

Is optical imaging spectroscopy a viable measurement technique for the investigation of the negative BOLD phenomenon? A concurrent optical imaging spectroscopy and fMRI study at high field (7 T)
por: Kennerley, Aneurin J., et al.
Publicado: (2012)

Physiological and Pathological Brain Activation in the Anesthetized Rat Produces Hemodynamic-Dependent Cortical Temperature Increases That Can Confound the BOLD fMRI Signal
por: Harris, Samuel S., et al.
Publicado: (2018)

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
por: Scaricamazza, Silvia, et al.
Publicado: (2022)

Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis
por: Baker, David J., et al.
Publicado: (2015)

Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Riancho, Javier, et al.
Publicado: (2015)

Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor
por: Nam, Sung Min, et al.
Publicado: (2021)

ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis
por: McGown, Alexander, et al.
Publicado: (2016)

Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis
por: Lougheed, Rosamond, et al.
Publicado: (2011)

Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis
por: OLIVÁN, Sara, et al.
Publicado: (2014)

Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis
por: Rizzuto, Emanuele, et al.
Publicado: (2015)

Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Novoselov, Sergey S., et al.
Publicado: (2013)

Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model
por: de Oliveira, Gabriela P., et al.
Publicado: (2013)

Distribution Features and Potential Effects of Serotonin in the Cerebrum of SOD1 G93A Transgenic Mice
por: He, Pei, et al.
Publicado: (2022)

Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2023)

Cromolyn sodium delays disease onset and is neuroprotective in the SOD1(G93A) Mouse Model of amyotrophic lateral sclerosis
por: Granucci, Eric J., et al.
Publicado: (2019)

Administration of 4-(α-L-Rhamnosyloxy)-benzyl Isothiocyanate Delays Disease Phenotype in SOD1(G93A) Rats: A Transgenic Model of Amyotrophic Lateral Sclerosis
por: Galuppo, Maria, et al.
Publicado: (2015)

LRP-1-mediated intracellular antibody delivery to the Central Nervous System
por: Tian, Xiaohe, et al.
Publicado: (2015)

The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice
por: Valsecchi, Valeria, et al.
Publicado: (2020)

MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1(G93A) Motor Neuron of Amyotrophic Lateral Sclerosis
por: Peng, Jialing, et al.
Publicado: (2022)

Targeting autotaxin impacts disease advance in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis
por: Gento‐Caro, Ángela, et al.
Publicado: (2021)

Sex and HDAC4 Differently Affect the Pathophysiology of Amyotrophic Lateral Sclerosis in SOD1-G93A Mice
por: Renzini, Alessandra, et al.
Publicado: (2022)

In Vivo Fiber Optic Raman Spectroscopy of Muscle in Preclinical Models of Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy
por: Plesia, Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aa7d2ernu4gu2og078q1d4cb65